DK0555333T3 - Kunstige virushylstre - Google Patents

Kunstige virushylstre

Info

Publication number
DK0555333T3
DK0555333T3 DK91919952.1T DK91919952T DK0555333T3 DK 0555333 T3 DK0555333 T3 DK 0555333T3 DK 91919952 T DK91919952 T DK 91919952T DK 0555333 T3 DK0555333 T3 DK 0555333T3
Authority
DK
Denmark
Prior art keywords
viral envelopes
virus envelopes
artificial virus
production
envelopes
Prior art date
Application number
DK91919952.1T
Other languages
English (en)
Inventor
Hans Schreier
Ramesh Chander
Arlene A Stecenko
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of DK0555333T3 publication Critical patent/DK0555333T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK91919952.1T 1990-10-19 1991-10-17 Kunstige virushylstre DK0555333T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60064190A 1990-10-19 1990-10-19

Publications (1)

Publication Number Publication Date
DK0555333T3 true DK0555333T3 (da) 1996-04-29

Family

ID=24404456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919952.1T DK0555333T3 (da) 1990-10-19 1991-10-17 Kunstige virushylstre

Country Status (8)

Country Link
EP (1) EP0555333B1 (da)
JP (1) JP3414395B2 (da)
AT (1) ATE132034T1 (da)
DE (1) DE69115924T2 (da)
DK (1) DK0555333T3 (da)
ES (1) ES2081502T3 (da)
GR (1) GR3018918T3 (da)
WO (1) WO1992006677A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2369491C (en) 2000-02-02 2008-09-02 Yasufumi Kaneda Virus envelope vector for gene transfer
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
DE60137953D1 (de) 2000-10-06 2009-04-23 Life Technologies Corp Zellen mit spektraler signatur sowie verfahren zu ihrer herstellung und nutzung
EP1447080A1 (en) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Method for producing virosome-like particles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2650502C3 (de) * 1976-11-04 1980-01-17 Karl Dr.Med. 7302 Ostfildern Theurer Herstellung von Liposomen welche Arzneistoffe enthalten
EP0032578B1 (de) * 1980-01-16 1984-07-25 Hans Georg Prof. Dr. Weder Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
LU86736A1 (fr) * 1987-01-15 1988-08-23 Univ Bruxelles Liposomes sensibilises a des molecules antigeniques de parasites intracellulaires,procede pour les preparations et leurs applications comme moyens de diagnostic et comme agents d'immunisation
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production

Also Published As

Publication number Publication date
EP0555333B1 (en) 1995-12-27
ES2081502T3 (es) 1996-03-16
ATE132034T1 (de) 1996-01-15
DE69115924D1 (de) 1996-02-08
JP3414395B2 (ja) 2003-06-09
GR3018918T3 (en) 1996-05-31
JPH06502412A (ja) 1994-03-17
DE69115924T2 (de) 1996-05-23
EP0555333A1 (en) 1993-08-18
WO1992006677A1 (en) 1992-04-30

Similar Documents

Publication Publication Date Title
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
SE8101266L (sv) Arkmaterial for kardiovaskulera och andra protesimplantat
ATE62255T1 (de) Kovalent modifizierte bakterielle polysaccharide, stabile kovalente konjugate von diesen polysacchariden und immunogenischen proteinen mit zweiwertigen bruecken und verfahren zur herstellung von solchen polysacchariden und konjugaten und zur befestigung der kovalenz.
SE9102975D0 (sv) Bakterofag och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
DK401981A (da) Herpes simplex type 1 underenhed vaccine og fremgangsmaade til fremstilling deraf
JPS5753410A (en) A type hepatitis virus high value production
ATE114713T1 (de) Biomasse zur produktion von virus/virusantigen.
DK0555333T3 (da) Kunstige virushylstre
ATE127526T1 (de) Verfahren zur herstellung von natürlichem hiv- glykoprotein 160.
ITRM920350A0 (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
SE8100614L (sv) Humant relaxin och sett for framstellning derav
DE69109910D1 (de) Herstellung von Ethyl-tert.alkyläthern.
DE69011856D1 (de) Herstellung von hefeextrakt.
DE3587351D1 (de) Haemoglobin mit reduziertem virusrisiko und dessen herstellung.
DK0498905T3 (da) Tilpassede epitoper af human immundeficiensvirus kappeglycoprotein gp120
DK447587D0 (da) Oxolabdaner, deres fremstilling og anvendelse
NL300073I1 (nl) Vaccin.
IT9019153A0 (it) Valvola cardiaca artificiale, con elevatissimo grado di sicurezza
ES2064071T3 (es) Antigeno viral de hepatitis delta, procedimiento para su purificacion y su utilizacion.
DE69227368T2 (de) Herstellung von hepatitis a virus
ES2074085T3 (es) Precursor de la glicoproteina de envolvente del retrovirus hiv-2 y antigenos emparentados.
LT2569B (lt) Kultivuojamu hibridiniu lasteliu musmusculus-l linija produkuojanti monokloninius antikunus pries galviju leukozes viruso baltyma p24
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids